The global peripheral vascular diagnostic systems market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of diabetes and critical limb ischemia, rising awareness about peripheral vascular diseases, and technological advancements in the field of diagnostics.
Diabetes and critical limb ischemia are two major drivers for the growth of this market. Diabetes affects more than 400 million people worldwide, with an estimated increase in prevalence to 600 million by 2030. Critical limb ischemia (CLI) affects more than 10 million people worldwide with an estimated increase in prevalence to 15 million by 2030. CLI can lead to amputation or death if not treated on time; hence it has been identified as a major public health concern globally.
-The global population is aging, which will lead to an increase in the number of people with peripheral vascular disease.
-The development of new diagnostic systems and treatments for peripheral vascular disease will drive growth.
-Increasing awareness about peripheral vascular disease and its risk factors among the general public will also contribute to market growth.
-The increasing prevalence of diabetes, obesity, and hypertension among the general population will also fuel market growth.
Industry Growth Insights published a new data on “Peripheral Vascular Diagnostic Systems Market”. The research report is titled “Peripheral Vascular Diagnostic Systems Market research by Types (Diabetes, Critical Limb Ischemia), By Applications (ASCs, Hospitals, Physicians' Offices), By Players/Companies ArjoHuntleigh, Viasonix, OMRON Healthcare, Opto Circuits, ACI Medical Management, BioMedix, Dialog Devices, D.E. Hokanson, ELCAT, FUKUDA DENSHI, Koven Technology, LD Technology, MGC Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Peripheral Vascular Diagnostic Systems Market Research Report
By Type
Diabetes, Critical Limb Ischemia
By Application
ASCs, Hospitals, Physicians' Offices
By Companies
ArjoHuntleigh, Viasonix, OMRON Healthcare, Opto Circuits, ACI Medical Management, BioMedix, Dialog Devices, D.E. Hokanson, ELCAT, FUKUDA DENSHI, Koven Technology, LD Technology, MGC Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Peripheral Vascular Diagnostic Systems Market Report Segments:
The global Peripheral Vascular Diagnostic Systems market is segmented on the basis of:
Types
Diabetes, Critical Limb Ischemia
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
ASCs, Hospitals, Physicians' Offices
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ArjoHuntleigh
- Viasonix
- OMRON Healthcare
- Opto Circuits
- ACI Medical Management
- BioMedix
- Dialog Devices
- D.E. Hokanson
- ELCAT
- FUKUDA DENSHI
- Koven Technology
- LD Technology
- MGC Diagnostics
Highlights of The Peripheral Vascular Diagnostic Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diabetes
- Critical Limb Ischemia
- By Application:
- ASCs
- Hospitals
- Physicians' Offices
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peripheral Vascular Diagnostic Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peripheral vascular diagnostic systems (PVDs) are medical devices that help diagnose and monitor diseases of the peripheral blood vessels. These devices include ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). PVDs can be used to detect problems such as atherosclerosis, thrombosis, and vasculitis.
Some of the major companies in the peripheral vascular diagnostic systems market are ArjoHuntleigh, Viasonix, OMRON Healthcare, Opto Circuits, ACI Medical Management, BioMedix, Dialog Devices, D.E. Hokanson, ELCAT, FUKUDA DENSHI, Koven Technology, LD Technology, MGC Diagnostics.
The peripheral vascular diagnostic systems market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Peripheral Vascular Diagnostic Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Peripheral Vascular Diagnostic Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Peripheral Vascular Diagnostic Systems Market - Supply Chain
4.5. Global Peripheral Vascular Diagnostic Systems Market Forecast
4.5.1. Peripheral Vascular Diagnostic Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Peripheral Vascular Diagnostic Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Peripheral Vascular Diagnostic Systems Market Absolute $ Opportunity
5. Global Peripheral Vascular Diagnostic Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Type
5.3.1. Diabetes
5.3.2. Critical Limb Ischemia
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Peripheral Vascular Diagnostic Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Application
6.3.1. ASCs
6.3.2. Hospitals
6.3.3. Physicians' Offices
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Peripheral Vascular Diagnostic Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Peripheral Vascular Diagnostic Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Peripheral Vascular Diagnostic Systems Demand Share Forecast, 2019-2029
9. North America Peripheral Vascular Diagnostic Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Application
9.4.1. ASCs
9.4.2. Hospitals
9.4.3. Physicians' Offices
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Type
9.7.1. Diabetes
9.7.2. Critical Limb Ischemia
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Peripheral Vascular Diagnostic Systems Demand Share Forecast, 2019-2029
10. Latin America Peripheral Vascular Diagnostic Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Application
10.4.1. ASCs
10.4.2. Hospitals
10.4.3. Physicians' Offices
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Type
10.7.1. Diabetes
10.7.2. Critical Limb Ischemia
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Peripheral Vascular Diagnostic Systems Demand Share Forecast, 2019-2029
11. Europe Peripheral Vascular Diagnostic Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Application
11.4.1. ASCs
11.4.2. Hospitals
11.4.3. Physicians' Offices
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Type
11.7.1. Diabetes
1.7.2. Critical Limb Ischemia
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Peripheral Vascular Diagnostic Systems Demand Share, 2019-2029
12. Asia Pacific Peripheral Vascular Diagnostic Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Application
12.4.1. ASCs
12.4.2. Hospitals
12.4.3. Physicians' Offices
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Type
12.7.1. Diabetes
12.7.2. Critical Limb Ischemia
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Peripheral Vascular Diagnostic Systems Demand Share, 2019-2029
13. Middle East & Africa Peripheral Vascular Diagnostic Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Application
13.4.1. ASCs
13.4.2. Hospitals
13.4.3. Physicians' Offices
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Peripheral Vascular Diagnostic Systems Market Size and Volume Forecast by Type
13.7.1. Diabetes
13.7.2. Critical Limb Ischemia
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Peripheral Vascular Diagnostic Systems Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Peripheral Vascular Diagnostic Systems Market: Market Share Analysis
14.2. Peripheral Vascular Diagnostic Systems Distributors and Customers
14.3. Peripheral Vascular Diagnostic Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ArjoHuntleigh
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Viasonix
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. OMRON Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Opto Circuits
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ACI Medical Management
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BioMedix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dialog Devices
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. D.E. Hokanson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ELCAT
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. FUKUDA DENSHI
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Koven Technology
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. LD Technology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. MGC Diagnostics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
